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Abstract. 
 
In the mammalian host, the cell surface of 
 
Trypanosoma brucei
 
 is protected by a variant surface 
glycoprotein that is anchored in the plasma membrane 
through covalent attachment of the COOH terminus to 
a glycosylphosphatidylinositol. The trypanosome also 
contains a phospholipase C (GPI-PLC) that cleaves this 
anchor and could thus potentially enable the trypano-
some to shed the surface coat of VSG. Indeed, release 
of the surface VSG can be observed within a few min-
utes on lysis of trypanosomes in vitro. To investigate 
whether the ability to cleave the membrane anchor of 
the VSG is an essential function of the enzyme in vivo, 
a GPI-PLC null mutant trypanosome has been gener-
ated by targeted gene deletion. The mutant trypano-
somes are fully viable; they can go through an entire 
life cycle and maintain a persistent infection in mice. 
Thus the GPI-PLC is not an essential activity and is not 
necessary for antigenic variation. However, mice in-
fected with the mutant trypanosomes have a reduced 
parasitemia and survive longer than those infected with 
control trypanosomes. This phenotype is partially alle-
viated when the null mutant is modified to express low 
levels of GPI-PLC.
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1. 
 
Abbreviations used in this paper
 
: CRD, cross-reacting determinant;
GPI, glycosylphosphatidylinositol; mf, hydrophobic membrane form; PI,
phosphatidylinositol; PLC, phospholipase C; VSG, variant surface glyco-
protein.
 
A
 
frican
 
 trypanosomes are unusual among protozoan
parasites in that they never enter host cells and yet
persist for extended periods of time in mammalian
blood and tissues. They are able to survive in the host be-
cause conserved cell surface polypeptides are shielded
from host antibodies by a dense monolayer of a single
polypeptide species, the variant surface glycoprotein (VSG).
 
1
 
The parasites are able to establish a persistent infection by
a system of antigenic variation, whereby a single trypano-
some stops expressing one VSG gene and starts expressing
another antigenically distinct VSG. The VSG is a ho-
modimer, each monomer consisting of an NH
 
2
 
-terminal
domain comprising 
 
z
 
350 residues and a COOH-terminal
domain(s) of 50 to 100 residues (Johnson and Cross, 1979).
The structure of the NH
 
2
 
-terminal domain is known in the
case of two VSGs (Blum et al., 1993) and shows a high de-
gree of conservation of tertiary structure but not primary
sequence. The VSG is anchored in the membrane by the
covalent attachment of the COOH-terminal carboxyl to a
glycosylphosphatidylinositol (GPI), the structure of which
was first solved for the VSG MITat 1.4 (Ferguson et al.,
1988). The GPI anchor is added to the VSG within 1 min
of the completion of protein synthesis (Ferguson et al.,
1986).
 
Trypanosoma brucei
 
 contains an endogenous phospholi-
pase C (PLC) known as the GPI-PLC (Bülow and Over-
ath, 1986; Fox et al., 1986; Hereld et al., 1986) that is capa-
ble of hydrolyzing the GPI anchor on the VSG, releasing
dimyristyl glycerol (Ferguson et al., 1985). The result of
this hydrolysis is to convert the hydrophobic membrane
form VSG (mfVSG) to a water soluble VSG (sVSG; Car-
doso de Almeida and Turner, 1983), and hypotonic lysis
(Cardoso de Almeida and Turner, 1983) or stress (Voor-
heis et al., 1982; Rolin et al., 1996) results in the shedding
of the VSG from the membrane. This conversion can be
detected immunologically as it results in the exposure of
the cross-reacting determinant (CRD; Holder and Cross,
1981; Cardoso de Almeida and Turner, 1983), an epitope
contained in the residue of the anchor left attached to the
VSG after PLC hydrolysis. Consequently mfVSG is poorly
recognized by anti-CRD antibodies when compared with
sVSG. As well as the VSG, the majority of the precursors
of the GPI anchor are also substrates for the GPI-PLC in
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vitro (for review of GPI biosynthesis see McConville and
Ferguson, 1993). Recently, it has been shown that 
 
T. bru-
cei
 
 GPI-PLC can hydrolyze phosphatidylinositol (PI) un-
der certain assay conditions (Bütikofer et al., 1996). How-
ever the 
 
K
 
m
 
 for PI, 37 
 
m
 
M, is one to two orders of
magnitude higher than that for GPI-linked proteins (0.4–
0.7 
 
m
 
M for VSG [Bülow and Overath, 1986; Mensa-Wil-
mot and England, 1992], 0.8 
 
m
 
M for acetyl choline esterase
[Bütikofer et al., 1996]), so, at equivalent substrate con-
centrations, the GPI-PLC would preferentially cleave GPI
over PI, at least in vitro. It is therefore worth noting that
the number of VSG and PI molecules per trypanosome is
in fact roughly equivalent at 1.13 
 
3
 
 10
 
7
 
 molecules of the
VSG (Jackson et al., 1985) and 
 
z
 
2.7 
 
3
 
 10
 
7
 
 molecules of PI
(Voorheis and Martin, 1980; Carroll and McCrorie, 1986).
However, the observation that the PLC is active against
both GPI and PI has added to the confusion concerning its
function.
If GPI-PLC acts on a single GPI-anchored protein, then
the VSG is the most obvious candidate. The VSG is by or-
ders of magnitude the most abundant GPI-anchored pro-
tein in bloodstream trypanosomes, yet at 
 
z
 
3 
 
3
 
 10
 
4
 
 mole-
cules of GPI-PLC/trypanosome (Hereld et al., 1986) and
at an estimated turnover rate of 100 to 700 mfVSG mole-
cules/min under assay conditions (Hereld et al., 1986;
Mensa-Wilmot and Englund, 1992), there is sufficient
GPI-PLC to release the entire surface coat in a few min-
utes, as occurs on hypotonic or detergent lysis of trypano-
somes. The question that arises is whether the GPI-PLC
acts on the VSG at a point other than lysis. A low rate of
sVSG release from trypanosomes has been observed in
cultures of bloodstream forms and clearly demonstrated
not to result from lysis of a subset of the population
(Bülow et al., 1989
 
b
 
). In addition, release of sVSG can be
induced under stress conditions that do not lyse trypano-
somes (Rolin et al., 1996). Both of these observations sug-
gest that GPI-PLC acts on mfVSG in living trypanosomes,
not just on cell lysis.
Furthermore, VSG and GPI-PLC show the same devel-
opmentally regulated expression, being found in blood-
stream but not in procyclic trypanosomes, i.e., the form
that is present in the insect midgut (Bülow and Overath,
1985; Carrington et al., 1989; Mensa-Wilmot et al., 1990).
GPI-PLC expression also coincides with GPI-anchor sen-
sitivity to GPI-PLC cleavage; all GPI anchors analyzed to
date in procyclic trypanosomes are GPI-PLC resistant
(Field et al., 1991; Engstler et al., 1992). In the case of the
major surface protein, procyclin, this is due to palmitoyla-
tion of the inositol ring (Field et al., 1991).
The main evidence against mfVSG constituting the in
vivo substrate for GPI-PLC is its membrane topology.
GPI-PLC acts as an integral membrane protein, despite
lacking any predicted membrane spanning sequences (Car-
rington et al., 1989; Mensa-Wilmot et al., 1990) and ap-
pears to be predominantly localized to the cytoplasmic
face of intracellular vesicles (Bülow et al., 1989
 
a
 
). The VSG
and GPI-PLC must be in the same membrane for a reac-
tion to occur (Bülow and Overath, 1986) and presumably
also orientated on the same side of the membrane. So,
given their location in the cell and without a mechanism
for translocating the enzyme across a membrane, GPI-PLC
could not gain access to mfVSG.
 
The ability of the GPI-PLC to catalyze the shedding of
the VSG coat in vitro, and the cotemporal expression of
the two proteins, has led to models that suggest an impor-
tant role for the enzyme in the developmental changes
that involve alterations in expression of cell surface pro-
teins (Carrington et al., 1991). There are three circum-
stances when a trypanosome must replace its surface VSG
and therefore when a specific VSG-shedding activity, such
as GPI-PLC, might be invoked. The first occurs within a
few days after entry into a mammalian host when all cells
exchange the metacyclic VSG, expressed in the insect sali-
vary gland, for a bloodstream form VSG (Esser and
Schoenbechler, 1985). The second occasion may arise in
the individual trypanosomes undergoing antigenic varia-
tion. In both cases, a passive exchange of new for old VSG,
based on measurements of VSG turnover (Bülow et al.,
1989
 
b
 
) in combination with growth and dilution, would
take several generations, so a process for more rapid ex-
change has obvious advantages in a host that is mounting
an immune response to the old VSG. As antigenic varia-
tion occurs in a very small fraction of the population, it has
not been possible to determine whether this occurs. The
third is on the differentiation of bloodstream to procyclic
trypanosomes that occurs on ingestion by the insect vector
and involves the replacement of surface VSG with procy-
clin (Roditi et al., 1989). Although the increase in rate of
VSG shedding on this differentiation can be fully ex-
plained by the activation or induction of a specific pro-
tease (Ziegelbauer et al., 1993), the fate of the GPI-linked,
COOH-terminal peptide remains unresolved.
Other biological substrates have been suggested for the
GPI-PLC. One or more of the GPI-PLC–sensitive GPI
precursors is an attractive proposition since a number are
found predominantly in the cytoplasmic leaflet of the en-
doplasmic reticulum (Vidugiriene and Menon, 1993; Mensa-
Wilmot et al., 1994) and are thus topologically available to
the GPI-PLC. It has been suggested that 
 
T. brucei
 
 GPI-
PLC may play a role in the regulation of GPI levels
(Güther et al., 1994; Güther and Ferguson, 1995) or PI lev-
els (Bütikofer et al., 1996) within the cell. However, it is
not immediately obvious why a general role in (G)PI me-
tabolism or homeostasis, unlike expression of GPI-PLC
and VSG, would be confined to the bloodstream stage of
the life cycle.
Most of the circumstantial evidence outlined above thus
points to a role for the GPI-PLC in the hydrolysis of the
GPI anchor of the VSG. To address directly the role of
this, a GPI-PLC null mutant (
 
PLC
 
2
 
) has been generated
and its phenotype studied. The GPI-PLC is not an essen-
tial activity, but 
 
PLC
 
2
 
 trypanosomes display an altered
persistent infection in mice.
 
Materials and Methods
 
Construction of the Chimeric Selectable
Marker Genes
 
The neo
 
R
 
 and hyg
 
R
 
 antibiotic resistance genes were constructed to a stan-
dard format. The procyclin mini-exon acceptor site and 5
 
9
 
 untranslated re-
gion (UTR) was followed by the coding sequence of the resistance gene
and then the 3
 
9
 
 UTR and polyadenylation site of a 
 
T. brucei
 
 
 
b
 
-tubulin
gene. The constructs were derived from pJF6 (Clayton et al., 1990). The
chloramphenicol acetyl transferase gene was removed by HindIII–BamHI 
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digestion and replaced, in a three-fragment ligation, by a HindIII–EcoRI
fragment containing the coding sequence and an EcoRI–BglII fragment
from the 
 
b
 
-tubulin gene. The restriction sites were added to the coding se-
quence using PCR or adaptors.
 
PLC Gene Deletion Constructs, pLN and pSH
 
The gene encoding GPI-PLC (
 
PLC
 
) and flanking DNA was subcloned
from 
 
l
 
BS2 (Carrington et al., 1989) and 
 
l
 
BS3 as a 9.4-kb EcoRI–SalI
fragment. This plasmid is referred to as p1172. An XbaI site was intro-
duced downstream of the GPI-PLC gene, after the polyadenylation sites
(see Fig. 1 
 
a
 
) by site-directed mutagenesis to give p1172x. The ILTar 1 se-
rodeme (Miller and Turner, 1981) is heterozygous for an insertion type
RFLP in the intergenic region upstream of the GPI-PLC gene (see Fig. 1
 
a
 
). Since the constructs were originally designed to target this trypano-
some line, both alleles were cloned as PCR products, and a KpnI site was
introduced into each by site directed mutagenesis (see Fig. 1 
 
a
 
). These
were subcloned back into p1172x as a ClaI–BstEII fragment, in place of
the endogenous ClaI–BstEII fragment, to give two constructs, p1172kxL
and p1172kxS containing the long and short RFLP allele, respectively.
The trypanosome line actually used for the gene deletion (see below) is
homozygous for the long RFLP.
The entire GPI-PLC gene was then removed from these plasmids as a
KpnI–XbaI fragment and replaced with the neo
 
R
 
 expression cassette
(p1172kxL) or the hyg
 
R
 
 cassette (p1172kxS) to give pLN and pSH, respec-
tively. The restriction sites were added to the chimeric antibiotic resis-
tance genes using PCR.
 
PLC Replacement Construct, pB
 
The 
 
PLC
 
 replacement construct (see Fig. 1 
 
b
 
) was designed to integrate a
copy of the 
 
PLC
 
 gene into the tubulin gene cluster, which in 
 
T. brucei
 
 is
comprised of an 
 
a
 
 and 
 
b
 
 tubulin gene pair tandemly arrayed 12 to 15
times. The coding sequence of the 
 
ble
 
R
 
 gene, including the termination
codon, from pUT58 (CAYLA), was used to replace part of the coding se-
quence of an 
 
a
 
 tubulin gene from the initiation codon to the StuI site. In
the adjacent 
 
b
 
 tubulin gene the entire coding sequence was precisely re-
placed with the GPI-PLC coding sequence. The encoded mRNA there-
fore consists of the GPI-PLC coding sequence with 
 
b
 
 tubulin 5
 
9
 
 and 3
 
9
 
UTRs. Where necessary, restriction enzyme sites were added using PCR.
 
Trypanosomes
 
The procyclic trypanosome line used, pro G Anvers, was derived from the
EATRO 1125 (Van Meirvenne et al., 1975) stock by recent passage
through tsetse flies and kept in culture for only 40 d after isolation from
the fly. Procyclics were cultured in SDM-79 (Brun and Schönenberger,
1979) with 10% vol/vol heat-inactivated fetal bovine serum. Bloodstream
forms were grown in mice and purified from blood by DEAE-cellulose
chromatography (Lanham and Godfrey, 1970). Immunosuppressed mice
were prepared by X-irradiation (550–600 radons).
 
Nucleic Acids and Proteins
 
Preparation, gel electrophoresis, and blotting of nucleic acids were per-
formed as described previously (Carrington et al., 1987). SDS-PAGE and
Western blotting were performed using standard techniques. Primary
antibodies were used at 1 to 5 
 
m
 
g/ml. The secondary antibodies were per-
oxidase-conjugated donkey anti–rabbit immunoglobulin or peroxidase-
conjugated rabbit anti–mouse immunoglobulin and were used at the man-
ufacturer’s recommended concentrations (Jackson ImmunoResearch
Laboratories, West Grove, PA). Detection was by chemiluminescence
(Amersham, Intl., Arlington Heights, IL). Alternatively, secondary anti-
body was alkaline phosphatase-linked anti–rabbit immunoglobulin (Boeh-
ringer Mannheim, Indianapolis, IN), and the detection used a chromo-
genic substrate.
 
Antibodies
 
Anti–GPI-PLC was prepared by immunizing a rabbit with a 
 
l
 
cro-
 
b
 
-galac-
tosidase–GPI-PLC fusion protein. This was prepared by cloning the end-
filled DraI–EcoRI fragment from pBS1, containing a GPI-PLC cDNA
(Carrington et al., 1989), into the SmaI site of pEX3 (Genofit, Grand-
Lancy, France). The fusion protein was insoluble and was separated from
the other insoluble proteins by preparative SDS-PAGE. The antibodies
were affinity purified on a glutathione-S-transferase–GPI-PLC fusion pro-
 
tein (gst-plc) attached to Sepharose beads. The gst-plc was made by clon-
ing the entire GPI-PLC coding sequence into the EcoRI and BamHI sites
of pGEX2T (Pharmacia Fine Chemicals, Piscataway, NJ), the restriction
sites being added to the cDNA using PCR. The gst-plc was insoluble and
was purified by preparative SDS-PAGE. The anti-CRD was a kind gift of
Dr. Paul Englund (Johns Hopkins Medical School, Baltimore, MD; see
Fig. 3 
 
a
 
) and Dr. Linda Allen (Cambridge University, Cambridge, UK; see
other figures).
 
Electroporation and Transformation of Procyclic 
Form T. brucei
 
Procyclic trypanosomes were grown to a density of 6 to 8 
 
3
 
 10
 
6
 
 cells/ml,
washed, and resuspended in ZPFM solution (Zimmerman, 1982) at a den-
sity of 4 
 
3
 
 10
 
7
 
 cells/ml. 300-
 
m
 
l aliquots were mixed with 15 
 
m
 
g DNA in 4-mm
cuvettes and electroporated twice at 1.5 kV, 25 
 
m
 
F, 200 ohms in a gene
pulser (Bio Rad, Hercules, CA). These cells were used to seed a 10-ml cul-
ture, and antibiotic selection was introduced 24 h after electroporation.
For elimination of the 
 
PLC
 
 gene, cells were first transformed to G418 re-
sistance, using pLN, and then the uncloned population transformed to hy-
gromycin resistance, using pSH. Doubly resistant trypanosomes were
cloned by dilution into 40% vol/vol fresh conditioned medium with antibi-
otic selection. A single 
 
PLC
 
2
 
 clone was converted to bloodstream form by
transmission through tsetse flies. For 
 
PLC
 
 replacement, the same procy-
clic 
 
PLC
 
2
 
 was transformed to phleomycin resistance using pB and cloned
as above before tsetse transmission.
 
Trypanosome Extracts
 
SDS lysates were prepared by resuspending cells in SDS-PAGE sample
buffer at 2 
 
3
 
 10
 
8
 
 cells/ml and immediately incubating at 100
 
8
 
C for 3 mins.
Hypotonic lysates (Fig. 3 
 
a
 
) were prepared by resuspending cells in TES
buffer (20 mM TES, pH 7.5, 140 mM NaCl, 5 mM KCl, 10 mM glucose, 1
mM EDTA, 1 mM PMSF, 50 
 
m
 
g/ml leupeptin) at 3 
 
3
 
 10
 
9
 
 cells/ml and then
diluting to 2 
 
3
 
 10
 
8
 
 cells/ml with hypotonic dilution buffer (1 mM EDTA, 1
mM PMSF, 50 
 
m
 
g/ml leupeptin). The lysates were incubated for 5 min at
37
 
8
 
C. PI-PLC treatment involved incubation of hypotonic lysates with 4 U
 
Bacillus cereus
 
 PI-PLC (Boehringer) per 1 
 
3
 
 10
 
6
 
 cells for 30 min at 37
 
8
 
C.
In other experiments, as an alternative to hypotonic lysis, cells were lysed
in 1% Triton X-100 in TES buffer at a concentration of 2 
 
3
 
 10
 
8
 
 cells/ml.
The preparation of recombinant GPI-PLC will be described elsewhere. In
all the experiments in this paper the GPI-PLC was added in sufficient
quantities to completely hydrolyze the GPI anchor of the VSG in 5 min at
37
 
8
 
C.
 
GPI-PLC Assays
 
These were performed using [
 
3
 
H]-myristyl VSG as substrate and counting
the 
 
3
 
H released into an organic phase on phase separation (Bülow and
Overath, 1986). 3 
 
m
 
g of VSG that contained 10,000 cpm 
 
3
 
H was used as
substrate in a 200-
 
m
 
l reaction with 4 
 
3
 
 10
 
6
 
 cell equivalents of trypano-
somes lysed in TES buffer containing 1% Triton X-100.
 
In Vitro Differentiation from Bloodstream to
Procyclic Form
 
Trypanosomes were grown in immunosuppressed mice for 7 d, until the
parasite population was predominantly stumpy in morphology. Differenti-
ation was induced as described (Rolin et al., 1993); briefly, cells were in-
noculated at a density of 1 
 
3
 
 10
 
6
 
 cells/ml into modified DTM (Overath et
al., 1986) with 15% heat-inactivated fetal calf serum and 3 mM citrate/
 
cis
 
-
aconitate and incubated at 27
 
8
 
C in 4% CO
 
2
 
 in air (Ziegelbauer et al.,
1990).
 
FACS
 
®
 
 Analysis
 
FACS
 
®
 
 analysis was performed as previously described (Rolin et al.,
1993). A mixture of three anti-sera (anti-AnTat 1.1, 1.2, and 1.3) was suf-
ficient to detect the VSG using FACS
 
®
 
. The anti-procyclin was the mono-
clonal antibody TPRI/247 (Cedarlane, Hornby, Ontario, Canada).
 
Chronic Infections of Mice
 
The different trypanosome stocks being tested were injected intraperito-
neally (i.p.) into each of six matched CFLP mice using an innoculation of 
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1 
 
3
 
 10
 
6
 
 trypanosomes, unless otherwise stated. Parasite densities in subse-
quent infections were determined using an improved Neubauer haemocy-
tometer after dilution of tail blood into 0.85% ammonium chloride. The
minimum detectable density was 4 3 104 trypanosomes/ml. Infections
were monitored daily for the first 24 d and then 3–4 times a week until 90–
100 d after infection. Mice were removed from the study on exhibiting se-
vere clinical symptoms such as inability to walk, hunched appearance, and
labored breathing.
Statistical Analysis
Mann-Whitney tests were used to compare parasitemias at the first peak
and survival times between groups. Probability values were adjusted for
ties where appropriate. A probability value of <0.05 was taken to indicate
a significant difference.
Immunofluorescence
Trypanosomes were purified from blood and fixed in suspension with 4%
paraformaldehyde in PBS for 10 min. After washing with PBS, the cells
were allowed to settle onto polylysine-coated multiwell slides. The re-
mainder of the procedure followed standard protocols; the mouse serum
was diluted 1:500.
Results
Design of the PLC Elimination Constructs
The approach taken to generate a GPI-PLC null mutant T.
brucei cell line was targeted deletion of the gene by ho-
mologous recombination (Lee and Van der Ploeg, 1990;
ten Asbroek et al., 1990; Eid and Sollner-Webb, 1991).
There is a single PLC gene per haploid genome (Car-
rington et al., 1989), and since T. brucei is diploid, two suc-
cessive deletions were performed using the selectable
marker cassettes neoR and hygR, coding for neomycin and
hygromycin phosphotransferase, respectively. The target-
ing constructs were designed to affect removal of the en-
tire PLC gene, including both 59 and 39 UTRs. The end
points of the deletion were also chosen to minimize any in-
terference with the expression of flanking genes, and the
untranslated regions were removed to avoid any influence
that they might exert on marker gene expression. The de-
sired deletion resulted in the elimination of the entire
PLC gene from before the dominant mini-exon addition
site to beyond the polyadenylation sites, but left the pro-
cessing sites of the flanking genes untouched. The gene
targeting constructs are shown in Fig. 1 a, along with a
map of the genome before and after a favorable recombi-
nation event. The determination of the RNA processing
sites for the PLC and flanking genes will be published
elsewhere. The deletions were performed in procyclic try-
panosomes that do not express GPI-PLC and thus should
present no phenotype and be at no selective disadvantage.
Cells were subsequently induced to differentiate to a form
that usually expresses the enzyme.
Elimination of the PLC Gene
Before electroporation, constructs were linearized to in-
crease the efficiency of stable integration and to favor a
gene replacement (ten Asbroek et al., 1993). Trypano-
Figure 1. Structure and re-
striction enzyme maps of the
PLC and tubulin loci, the
constructs with which they
were targeted, and the de-
sired homologous recombi-
nation products. None of the
constructs contains promot-
ers but rely on polycistronic
transcription for selectable
marker expression. (a) Dele-
tion of the PLC gene; struc-
ture of genome shows the
sites of polyadenylation (pA)
for the PLC gene and the
main sites of mini-exon addi-
tion (ME) for both the PLC
gene and the downstream
gene, gene 3. These were
mapped by RNase protection
analysis (data not shown).
Boxes represent coding se-
quences. K* (KpnI) and X*
(XbaI) mark the positions of
restriction sites introduced
into genomic clones by site-
directed mutagenesis. Con-
structs shows the PLC elimi-
nation constructs in which the PLC gene has been replaced by a chimeric expression cassette. The two constructs differ in the presence
of either the long or short version of an RFLP in the intergenic region. The BglI (Bg) sites were used to linearize constructs before elec-
troporation. Desired recombination product shows the genome after targeting. (b) PLC replacement. Structure of genome shows a rep-
resentative section of the T. brucei tubulin gene cluster. Construct shows the PLC replacement construct, based on a PstI to PstI frag-
ment that includes two complete a tubulin genes separated by one entire b tubulin gene. BamHI sites were used in Southern analysis of
transformed cell lines. The other restriction sites were involved in construction: BstEII (Bs), ClaI (C), HindIII (H), MluI (M), NcoI (N),
StuI (St).Webb et al. GPI-PLC Null T. brucei 107
somes were first transformed to G418 resistance and the
uncloned population subsequently transformed to hygro-
mycin resistance before clonal cell lines were established.
Southern analysis of doubly resistant clones showed that
the desired recombinational event occurred with high effi-
ciency (14/16 events analyzed, data not shown). A South-
ern blot of BamHI-digested genomic DNA probed with 59
flanking DNA (Fig. 1 a, probe B) is a way to distinguish
between construct insertion and gene replacement. Such
an analysis of the PLC2 clone selected for continued study
is shown in Fig. 2, in comparison with wild-type EATRO
1125 proG and a heterozygous G418-resistant clone dis-
playing a single PLC gene deletion. There is no hybridiza-
tion of a PLC coding sequence probe to the PLC2 ge-
nomic DNA (Fig. 2). Absence of the PLC gene was also
confirmed by PCR analysis (data not shown).
As expected, the PLC2 procyclic trypanosomes showed
no gross alterations in morphology or growth rate. A sin-
gle PLC2 clone was transmitted through tsetse flies. When
trypanosomes were visible in saliva from a fly they were
used to infect an immunosuppressed mouse. After further
amplification in an irradiated mouse, stabilates were pre-
pared.
Confirmation of Phenotype and Lack of Redundancy
Since PLC2 procyclic trypanosomes were able to differen-
tiate to bloodstream forms it is evident that GPI-PLC ac-
tivity is not necessary for these developmental steps. To
confirm the absence of GPI-PLC activity, the cleavage of
mfVSG to sVSG by endogenous enzymes was assayed in
PLC2 and control cells. A Western blot was used to deter-
mine whether the CRD was exposed (Fig. 3 a). The assay
would also detect any alternative activity, such as another
phospholipase C or a D, capable of hydrolyzing the GPI
anchor to expose the CRD.
On SDS lysis there is very rapid inactivation of GPI-
PLC, and the reaction of the VSG with the anti-CRD is
weak or nonexistent. Recognition of some mfVSGs has
been observed previously and seems to depend on an
epitope involving the galactose branch and ethanolamine
phosphate bridge of the GPI anchor (Zamze et al., 1988).
The varying degree of galactosylation in different VSG an-
chors may explain the differing reactivity of their intact
form with anti-CRD antibodies. The difference in mfVSG
electrophoretic mobility between the control and null cells
(Fig. 3 a, compare lanes 1 and 4) suggests that the predom-
inant VSG in the two populations is different. This is con-
sistent with the slight recognition of the mfVSG in the
SDS lysate of the PLC2, but not control trypanosomes.
On hypotonic lysis and incubation at 378C, the VSG in
the control trypanosomes but not PLC2 trypanosomes be-
came strongly CRD positive. This confirms the absence of
GPI-PLC activity in the null mutant and, furthermore, in-
dicates that there is no alternative endogenous metabolic
route to convert mfVSG to sVSG. The VSG in the PLC2
cells became CRD positive on incubation with exogenous
B. cereus PI-PLC. This result indicates that the GPI an-
chor on the VSG in the PLC2 cells contains PI and the
core oligosaccharide recognized by anti-CRD antibodies,
suggesting that the anchor structure is normal.
Absence of GPI-PLC activity in the PLC2 trypano-
somes was confirmed by assaying detergent lysates for
their ability to release tritium from [3H]-myristyl VSG.
Activity in the wild-type cells was 45 pmol/min/mg protein,
which is similar to previously reported values (Bülow and
Overath, 1986) and in null mutant cells was ,0.5 pmol/
min/mg protein, the limit of reliable detection of the activ-
ity. It is not clear whether the removal of a single myristic
acid from the GPI anchor by a phospholipase A would re-
sult in either VSG shedding or exposure of the CRD
epitope. However, failure to release tritium into the or-
ganic phase during the standard assay argues against the
presence of such a phospholipase in the PLC2 cells.
A further experiment was performed to investigate if
any other modifications to the GPI anchor could be de-
tected after lysis. In this case Triton X-100 lysis was used
and the lysate incubated at 378C for 20 or 40 min with or
without added recombinant GPI-PLC. In the absence of
added GPI-PLC, no anti-CRD binding was detected either
at 20 or 40 min, similar to the previous result. Addition-
ally, if the lysate was incubated first for 20 min in the ab-
sence of added GPI-PLC and the enzyme then was added
for the second 20 min of the incubation, the same strength
of anti-CRD signal was obtained (Fig. 3 b). This result
means that, in the absence of GPI-PLC gene, no modifica-
tions occurred to the GPI anchor that would affect hydrol-
ysis by GPI-PLC, such as acylation, hydrolysis by gluco-
nases, or hydrolysis by a phospholipase D.
It has already been reported that, unlike wild-type,
PLC2 trypanosomes do not release sVSG in stress condi-
tions (Rolin et al., 1996).
Differentiation of PLC2 Trypanosomes from 
Bloodstream to Procyclic Form
On ingestion by tsetse flies, bloodstream trypanosomes
differentiate to procyclic forms, a process that can be mim-
Figure 2. Southern analysis demonstrating elimination and sub-
sequent replacement of the PLC gene in EATRO 1125 proG
procyclic T. brucei. About 4 mg of genomic DNA from (a) parent
EATRO 1125 proG cells, (b) a G418 resistant line cloned after a
single PLC knock-out, (c) the PLC null mutant (PLC2) clone
and (d) a PLC1 null clone were digested with BamHI and probed
with probe B or PLC-coding sequence as indicated. Blots were
washed in 0.1 3 SSC, 0.1% SDS for 2 h at 608C. Sizes on the left
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icked in vitro (Ziegelbauer et al., 1990). Since the PLC2
mutant was first generated as a procyclic cell line, this dif-
ferentiation would complete the life cycle. Bloodstream-
form cells were harvested from irradiated mice 7 d after
infection when the population was predominantly stumpy
in morphology and hence predisposed to synchronous dif-
ferentiation (Ziegelbauer et al., 1990). A plot of cell den-
sity against time after cells were induced to differentiate is
given in Fig. 4. The control trypanosomes displayed a 15-h
lag before exponential growth of procyclic forms com-
menced. This is similar to results previously reported with
stumpy-form AnTat 1.1 cells (Ziegelbauer et al., 1990; Ro-
lin et al., 1993). The lag and subsequent growth rate of the
PLC2 trypanosomes were indistinguishable from the con-
trol and are within the normal range expected for this cell
line. The distinct morphological changes that occur in
wild-type cells during this time (Rolin et al., 1993) were
also apparent during differentiation of the PLC2 cells
(data not shown).
FACS® analysis (Roditi et al., 1989; Ziegelbauer et al.,
1990) was used to follow the kinetics of appearance of cell
surface procyclin and loss of VSG in the PLC2 trypano-
somes. In preliminary experiments, the VSG expressed by
the nonclonal PLC2 trypanosomes was investigated by
immunofluorescence. Of 12 antibodies tried (anti-AnTat
1.1 to anti-AnTat 1.12), 4 (AnTat 1.1, 1.2, 1.3, and 1.6)
were found to react weakly with some cells in the popula-
tion. The strength of the fluorescence indicated that the
VSG(s) expressed by the PLC2 trypanosomes was slightly
cross-reactive with these antibodies as opposed to actually
being one of these VSGs. A mixture of three of the anti-
sera (AnTat 1.1, 1.2, and 1.3) was sufficient to produce a
signal for the VSG that was detectable on FACS® analysis.
Fig. 5 shows that surface VSG has been completely re-
placed by procyclin between 7 and 9 h after initiation of
differentiation. Once again, this is consistent with previous
studies on this cell line (Rolin et al., 1993). Furthermore,
the transient activation of adenylate cyclase, which follows
VSG release during differentiation, occurs normally in the
PLC2 trypanosomes (Rolin et al., 1996). Finally, when
bloodstream forms were fed to tsetse flies, PLC2 trypano-
somes established a typical procyclic infection in the mid-
gut (data not shown). This indicates that the essentially
normal differentiation observed in vitro also occurs in
vivo.
PLC2 Trypanosomes Can Establish a 
Persistent Infection
The initial stabilates of the bloodstream form of PLC2 try-
panosomes were produced in immunosuppressed mice
and so had not interacted with the host immune system.
To establish a persistent infection in an immunologically
competent mouse, trypanosomes have to exchange the
metacyclic VSG for a bloodstream form VSG, and this oc-
curs in the majority of the population (Esser and Schoen-
bechler, 1985). Subsequently a small subset of the population
undergoes antigenic variation to avoid antibody-mediated
lysis. To test whether the VSG-shedding properties of GPI-
PLC play an essential part in these two processes, infections
were established in laboratory mice. Persistent infections
lasting .50 d were readily observed with the PLC2 blood-
stream-form population. Parasitemic profiles for six indi-
vidual mice for the first 50 d after infection are given in
Fig. 6. Each mouse shows the same basic pattern that is in
turn broadly similar to the profiles observed previously for
six cloned T. brucei stocks (Turner et al., 1995). An initial
peak of parasitemia is followed by a relapse and recrudes-
cence (‘trough’) to a comparatively level plateau, punctu-
ated by one or more further troughs.
Although it is barely credible that such an infection
could persist without antigenic variation, two experiments
were performed to show that VSG switching occurs in the
PLC2 trypanosomes. A clonal line of PLC2 trypanosomes
was first established by infecting immunosuppressed mice
Figure 3. Analysis of the VSG in PLC2 and control bloodstream
trypanosomes. (a) Cell extracts were prepared by SDS lysis, hy-
potonic lysis, and with addition of exogenous B. cereus PI-PLC to
the hypotonic lysate. Control cell extracts were loaded in lanes 1–3,
and the equivalent PLC2 trypanosome extracts in lanes 4–6. The
top panel shows a Coomassie blue-stained gel (2 3 106 cells/
track). Beneath is an equivalent gel (2 3 105 cells/track) that has
been Western blotted and probed with an anti-CRD polyclonal
antibody. (b) Trypanosome extracts were prepared by triton lysis
and incubated at 378C in the absence or presence of GPI-PLC.
The hydrolysis of the VSG by the GPI-PLC was monitored by
Western blotting the whole reaction using anti-CRD. 
Figure 4. Time course of trypanosome growth on differentiation
of control and PLC2 trypanosomes from bloodstream to procy-
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with single trypanosomes, and stabilates were made 10–14 d
later. Three mice were then infected using a single stabi-
late. The first mouse was used to prepare trypanosomes
for immunofluorescence during the first peak of para-
sitemia. The second mouse was used to prepare serum just
after the first peak of parasitemia had declined, and the
third mouse was used to prepare trypanosomes for immu-
nofluorescence during the second peak of parasitemia.
The results are shown in Fig. 7 a; the serum clearly recog-
nizes trypanosomes in the first peak, but not in the second.
In the second experiment, trypanosomes from the first
and a subsequent peak were used to produce detergent ly-
sates. The triton lysates were then treated with recombi-
nant GPI-PLC before Western blotting with anti-CRD
(Fig. 7 b). Both populations are expressing readily detect-
able VSG(s) that have different profiles on densitometric
analysis.
PLC2 Trypanosomes Have an Altered
Parasitemic Profile when Compared with Control
Cells in Model Infections
The course of chronic infection of mice with control try-
panosomes was monitored in parallel with the PLC2 in-
fections described above. Passage through a tsetse fly can
greatly alter the growth characteristics of a trypanosome
cell line (Turner, 1990). Therefore, the most comparable
trypanosome population available was used as a control in
infections. This population had been derived from the
same procyclic cell line as the PLC2 mutant and was trans-
mitted through tsetse flies in parallel, but had a chloram-
phenicol acetyl transferase-hygromycinR gene construct
integrated into the tubulin gene cluster (Berberof et al.,
1995). Since isolation from tsetse flies, both of the try-
panosome stocks had been amplified twice in immunosup-
pressed NMRI mice and stabilates prepared from the
second mouse. These stabilates were used to infect immu-
nosuppressed CFLP mice, and blood from these mice was
used to establish persistent infections in matched sets of
six CFLP mice. The innoculum for control and PLC2 try-
panosomes was matched as closely as possible; both were
collected while the parasitemia was rising and contained a
preponderence of long slender and intermediate forms as
opposed to stumpy forms. The differences between the
two parasitemic profiles are illustrated in Fig. 8, which
shows log10 geometric mean parasite density through time.
Although each infection within a group gave the same ba-
sic profile, slight variation in the timing of peaks and
troughs in individual mice means that the second and sub-
sequent troughs are evident only by large standard error
bars.
A parasitemia can be described in terms of the parame-
ters that provide the column headings in Table I (Turner
et al., 1995). Such characterization provided a clear dem-
onstration that different trypanosome stocks are intrinsi-
cally different in the parasitemias they produce in chronic
infections (Turner et al., 1995), and the same approach has
been adopted here to compare PLC2 with control try-
panosomes. The results are shown in Table I a, which also
summarizes the results of two additional, parallel, infec-
Figure 5. FACS® analysis showing the loss of VSG and the ap-
pearance of procyclin during the in vitro differentiation of PLC2
trypanosomes to procyclic forms.
Figure 6. The course of infection with PLC2 trypanosomes in six
individual mice. Parasite densities are expressed as log10 number
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tions with PLC2 trypanosomes. These were designed to
investigate whether prolonged growth in mice and innocu-
lum size altered the parasitemia. Syringe passaging of lab-
oratory trypanosome lines through mice is a standard
method for artificially increasing the level of parasitemia
achieved during infection. Thus two sets of six mice were
infected with PLC2 trypanosomes that had undergone 22
additional syringe passages in immunosuppressed CFLP
mice. One set of mice was infected with 1 3 106 trypano-
somes as above and a second set with 1 3 107 trypano-
somes.
The PLC2 trypanosomes show a more than threefold
decrease in first peak parasite density that was signifi-
cantly different (P 5 0.01) compared to control cells. In
this experiment, PLC2 trypanosome density never reached
1 3 108 cells/ml during the first 20 d of infection and for
most of the time the levels were ,1 3 107 cells/ml. The
control cells showed a higher overall parasitemia, .1 3
108 cells/ml for an average of 17.5% and ,1 3 107 cells/ml
for 32.5% of the first 20 d. Repeatedly passaging the
PLC2 trypanosomes resulted in an increased parasitemia
in the first 20 d, although all parameters indicated that the
parasitemia was still lower than with the control trypano-
somes and still statistically significant in the case of the
lower inoculum dose (P 5 0.01).
The survival time can be taken as an indication of the
virulence of an infection. The mean survival time of mice
infected with the control trypanosomes was 28 d, and was
Figure 7. Antigenic variation in PLC2 trypanosomes. (a) Immunofluorescence of trypanosomes from the first and a successive peak of
parasitemia using antiserum from a mouse that had just cleared the first peak. (b) A Western blot, probed with anti-CRD, showing the
effect of GPI-PLC treatment of total cell lysates from PLC2 trypanosomes from successive peaks of parasitemia. The enlarged panel
shows the CRD-positive VSGs from the two peaks; the densitometric scan of this region is shown below. Bar, 50 mm.
Figure 8. The course of infection in mice infected with control
and PLC2 trypanosomes for comparison of parasitemias. Results
are shown as geometric mean 6 2 standard errors, n 5 6. Arrow-
heads indicate the survival time of individual mice.Webb et al. GPI-PLC Null T. brucei 111
significantly (P 5 0.01) lower than in PLC2 trypanosome
infections, where the mean survival time was 81 d, and
three of the six mice were still alive at the end of the ex-
periment on day 99. Passaging and innoculum size of the
PLC2 trypanosomes had no significant effect on the sur-
vival time of the infected mice despite the higher overall
level of parasitemia compared with the unpassaged PLC2
trypanosomes. Survival time remained significantly differ-
ent from control infections at both inoculation size (P 5
0.05 and 0.01 for 106 and 107 trypanosomes, respectively).
The Altered Parasitemia in PLC2
Trypanosome Infections is Partially Rescued by
Low Level GPI-PLC Expression
The results above clearly showed that mice infected with
PLC2 trypanosomes had an altered parasitemic profile
when compared to the best available control. To address
the question as to whether this alteration was due to the
absence of the PLC gene, or some other event, a copy of
the PLC gene was returned to the PLC2 trypanosome. It
was decided to place the PLC gene in the tubulin locus (to
produce PLC1 trypanosomes) as opposed to returning it
to the endogenous position, as the latter manipulation
could conceivably repair any lesion in a flanking gene. The
targeting construct employed bleR as a selectable marker
and is shown in Fig. 1. Southern analysis of BamHI di-
gested DNA from one phleomycin resistant clone is shown
in Fig. 2 and shows that the PLC probe hybridises to a 6.6-
kb band, as expected after the desired integration into the
tubulin locus.
Phleomycin-resistant clones were transmitted through
tsetse flies, and the expression of GPI-PLC characterized
by Western blotting and assaying mfVSG to sVSG conver-
sion on hypotonic lysis. The PLC1 trypanosomes were
found to contain GPI-PLC protein but, by comparison
with a twofold dilution series of AnTat 1.1 cells (Fig. 9),
the level of GPI-PLC in 2 3 106 PLC1 trypanosomes was
roughly equivalent to that in only 1.25 3 105 AnTat1.1
cells. Thus the PLC1 trypanosomes contain approximately
one sixteenth of the wild-type, bloodsteam-form GPI-PLC
level. The presence of GPI-PLC activity was tested in two
assays. The first was detergent lysis of PLC1 trypano-
somes; in this assay the endogenous VSG became anti-
CRD positive (Fig. 10). In the second assay, lysates of
PLC1 and wild-type trypanosomes were assayed in vitro
for release of tritium from [3H]-myristyl VSG. The PLC1
trypanosome lysates contained an activity that released
15.5 pmol/min/mg protein or 31% of wild-type activity.
There is a discrepency between the estimates of the
amount of GPI-PLC protein (5–10% of wild-type) and the
activity (30% of wild-type). At this stage it is not clear
whether this is an artefact of the enzyme assay or due to
some endogenous regulatory phenomenon.
Matched sets of six mice were infected with either PLC2
or  PLC1 trypanosomes and the parasitemias monitored
over 93 d. The data are summarized in Table I b. The par-
asitemia and mouse survival data for the PLC2 parasites
in the two experiments were slightly different as might be
expected, but statistical comparison of parasitemias at first
peak and survivorship showed no significant differences
Table I. Comparison of Parasitaemias Produced on Infection of Mice with Various Trypanosome Lines; Mann-Whitney Tests Were 
Used to Compare Experimental Groups with the Control (Ia) or PLC2 with PLC1 (Ib), and p Values Are Given in Brackets
Trypanosome line
Median no.
of troughs*
Parasitaemia
at first peak‡
No. of days
pd .1 3 108 (%)§
No. of days
pd ,1 3 107 (%)§
Mean
survival time
Ia
Control 1 1.4 3 108 3.5 (17.5) 6.5 (32.5) 28.0
PLC2 3 4.1 3 107 (P 5 0.01) 0 12.8 (64.2) 81.3 (P 5 0.01)
PLC222p 2 7.4 3 107 (P 5 0.01) 1.2 (6.0) 11.2 (56) 72.8 (P 5 0.05)
PLC222p 1 3 107 1–2 7.2 3 107 (P 5 0.11) 1.2 (6.0) 10.2 (50.8) 90.5 (P 5 0.01)
Ib
PLC2 3 2.4 3 107 0.2 (0.8) 14.7 (73.3) 74.3
PLC1 1–2 9.4 3 107 (P 5 0.01) 2.2 (10.8) 9.7 (48.3) 56.7 (P 5 0.26)
*A trough is defined as a drop in parasitaemia greater than one order of magnitude between adjacent time points (calculated for the first 40 d).
‡Geometric means of parasite density at the peak of the first wave of parasitaemia (n 5 6, except for PLC2 22p, where n 5 5).
§The mean number of days on which parasite density (pd) was >1 3 108 cells per ml of blood, or <1 3 107 cells per ml of blood. These were determined for the first 20 d after
infection and are expressed as percentages in parentheses.
Figure 9. Expression of GPI-PLC protein in PLC1 trypano-
somes. Lysates of bloodstream trypanosomes from three lines;
AnTat 1.1, PLC2, and PLC1 trypanosomes were Western blot-
ted and probed with anti–GPI-PLC. All samples are from the
same blot and were probed simultaneously.The Journal of Cell Biology, Volume 139, 1997 112
(P 5 0.30 and P 5 0.47, respectively). Low level GPI-PLC
expression coincides with an increase in the parasitemia
over the first 20 d, with a significant increase in first peak
parasite density compared to the PLC2 infections (P 5
0.01). In addition there is a downward trend in mean sur-
vival time to values intermediate between the PLC2 and
wild-type trypanosomes, although this is not statistically
significant.
Discussion
The function of the GPI-PLC in T. brucei has been the
cause of much speculation, as the enzyme has an activity
that could theoretically facilitate the rapid shedding of the
protective VSG coat. A GPI-PLC null mutant has been
made by targeted gene deletion to test whether the ability
of the GPI-PLC to hydrolyze the GPI anchor of the VSG,
which is observed on both lysis and stress, is essential in
vivo. The generation of the mutant was facilitated by the
developmentally regulated expression of the PLC gene, as
the deletion could be performed in a life cycle stage that
does not express GPI-PLC. The success of the deletion
strategy is in accord with previous findings that integration
into the genome is the preferred mode of stable transfor-
mation in T. brucei and that integration is exclusively by
homologous recombination. The high efficiency with which
the desired recombinational event took place also sup-
ports the observation that constructs in which a drug-resis-
tance marker is flanked by noncontiguous homologous se-
quences tend to lead to homologous replacement of the
intervening sequences in the genome (Cruz and Beverley,
1990; Eid and Sollner-Webb, 1991; ten Asbroek et al.,
1993).
The major find presented in this paper is that PLC2 try-
panosomes are capable of completing an entire life cycle.
PLC2 mutants were generated as procyclic trypanosomes
and then subjected to cyclical transmission through tsetse
flies. The ability of cells isolated from the salivary glands
of tsetse flies to establish a chronic infection, at least in
mice, suggests that the enzyme is inessential for the mech-
anism of switching from metacyclic to bloodstream VSG
expression, or for the mechanism of antigenic variation.
Finally, PLC2 bloodstream trypanosomes have been dem-
onstrated to differentiate into procyclic trypanosomes
both in vitro and in vivo with apparently normal kinetics.
An absence of any redundant activity that could substi-
tute for the GPI-PLC had previously been suggested by
quantitative immunoprecipitation of the mfVSG to sVSG
activity in trypanosome lysates using a GPI-PLC–specific
monoclonal antibody (Bülow and Overath, 1986). The in-
ference that GPI-PLC is the only hydrolase catalyzing this
conversion has been confirmed by the absence of any
mfVSG-cleaving activity in PLC2 trypanosomes. This in
turn suggests that GPI-PLC is indeed responsible for the
low rate of CRD-positive VSG shedding that occurs from
living trypanosomes (Bülow et al., 1989; Seyfang et al.,
1990), and this could be confirmed if it becomes possible
to establish PLC2 trypanosomes in culture. The function
of this low rate of VSG shedding remains unclear. The via-
bility of the GPI-PLC null mutant indicates that it is not an
essential process in VSG turnover, although it may well af-
fect its kinetics. If the steady turnover of surface VSG in
wild-type cells (Seyfang et al., 1990) depends in part on the
action of GPI-PLC, coat exchange in the PLC2 trypano-
somes might be expected to take longer and involve a
longer period of double VSG expression. The possible im-
portance of this in determination of parasitemic profile is
highlighted by a certain mathematical model of antigenic
variation (Agur et al., 1989). Although a decrease in effi-
ciency of coat exchange may contribute to the change in
overall infection dynamics exhibited by the mutant PLC2,
it cannot explain certain characteristics such as the re-
duced height of first parasitemic peak.
In addition to the observed hydrolysis of the VSG an-
chor, it has been suggested that GPI-PLC may play a role
in GPI metabolism or that its primary function may be in
PI hydrolysis. The experiments in this paper allow some
observations to be made although they were not primarily
designed to address this subject.
Cleavage of the VSG from PLC2 trypanosomes by bac-
terial PI-PLC producing CRD-positive VSG strongly sug-
gests that the GPI anchor structure is normal and argues
against a role for GPI-PLC in GPI biosynthesis. Also, pre-
liminary analysis of the GPI biosynthetic pathway in
PLC2 trypanosomes indicates that the normal intermedi-
ates are present (Ferguson, M., and M.-L. Güther, per-
sonal communication).
However, GPI-PLC may yet play a part in the kinetics
of the biosynthetic pathway, perhaps in the catabolism of
excess GPI precursors since flux through the pathway is
apparently 10-fold in excess of absolute protein anchoring
requirements (Masterson and Ferguson, 1991). Such a cat-
abolic role may involve cleavage of one or more of the cy-
toplasmically disposed GPI precursors in the cytoplasmic
leaflet of the ER and would have to be tightly controlled
to preserve sufficient GPI to form VSG anchors. When
GPI-PLC is expressed in an heterologous system (Leish-
mania major) any such regulation is absent and cells se-
crete gp63 in a CRD-negative form because it never re-
ceives a GPI anchor (Mensa-Wilmot et al., 1994). It is not
clear to what extent these results are applicable to T. brucei.
Figure 10. Presence of GPI-PLC activity in PLC1 trypanosomes.
Western analysis of bloodstream trypanosomes from four cell
lines; AnTat 1.1, proG Anvers, PLC2 and PLC1. Lysates were
prepared by SDS or Triton lysis, Western blotted, and probed
with anti-CRD. All samples are from the same blot and were
probed simultaneously.Webb et al. GPI-PLC Null T. brucei 113
In T. brucei, there is a dynamic equilibrium between the
GPI-PLC-sensitive end-product of the biosynthetic path-
way that is attached to the VSG (glycolipid A) and an acy-
lated, GPI-PLC-resistant, form (glycolipid C; Güther et
al., 1994; Güther and Ferguson, 1995). Glycolipid C is not
an obligatory GPI precursor (Masterson and Ferguson,
1991) and, unlike most GPI intermediates, is predomi-
nantly localized in the lumenal leaflet of the ER (Vidugiri-
ene and Menon, 1994). The fact that it is kept both chemi-
cally and topologically secure from GPI-PLC attack is
intriguing. The role of glycolipid C is unclear, although it
may act as a store of GPI anchors and hence as a buffer
against fluctuating demands for GPI (Güther et al., 1994).
Preliminary analysis of the GPI biosynthetic pathway in
PLC2 trypanosomes indicates that there is no gross alter-
ation in the glycolipid A to C ratio, or accumulation of excess
GPI (Ferguson, M., and M.-L. Güther, personal communi-
cation). Although we cannot rule out a role for GPI-PLC
in catabolism of GPIs in vivo, it is clear that such a role is
not essential.
Any potential role of the GPI-PLC in PI metabolism is
more difficult to discuss in the absence of much knowledge
about signal transduction in trypanosomes. It is not possi-
ble, at this stage, to rule out a non-essential role for the
GPI-PLC involving PI hydrolysis. The loss of such a func-
tion in PLC2 trypanosomes may be rescued by a redun-
dant activity that does not metabolise GPI.
The second finding is that PLC2 trypanosomes have an
altered parasitemia in laboratory mice. The main differ-
ences between the PLC2 and control trypanosomes are
the degree of parasitemia in the early stages of a chronic
infection and the survival time of infected mice. However,
before an attenuated phenotype can be firmly assigned to
PLC2 trypanosomes it should be confirmed in indepen-
dently derived mutants, which are not yet available. Data
presented in this paper are based on the behavior of one
clone only. It should also be noted that the natural hosts
for T. brucei are mammals in sub-Saharan Africa and not
laboratory mice; the course of infection with PLC2 trypano-
somes in indigenous cattle may provide a more clearly de-
fined phenotype. In addition, confirmation should come
from a full phenotype rescue, which may only be possible
if PLC2 trypanosomes can be modified to express GPI-
PLC at wild-type levels. The possible partial rescue ob-
served in PLC1 trypanosomes is however encouraging.
There is variability in the parasitemia caused by different
isolates of T. brucei, but any one isolate produces a consis-
tent course of infection (Turner et al., 1995). The progress
of the initial stages of parasitemia (first 20 d) observed in
both control and PLC2 trypanosomes are within the range
reported for these different trypanosome isolates (Turner
et al., 1995). However, compared to the control trypano-
somes, the initial stages of parasitemia are reduced in
PLC2 trypanosomes, an effect that is partially reversed in
PLC1 trypanosomes. How could the absence of GPI-PLC
affect the initial parasitemia? Either the growth rate of the
PLC2 trypanosomes is reduced by an elongation of the
cell cycle time and/or increased rate of differentiation to
the nondividing stumpy forms. Alternatively the PLC2
trypanosomes could be killed more efficiently by the host
immune system. One possible mechanism for the latter is
that on immune lysis wild-type trypanosomes release sVSG
into the blood of the mouse which then acts as a decoy to
anti-VSG immunoglobulins as they are produced. It is
worth noting that blood with 1 3 108 trypanosomes/ml
contains roughly 100 mg/ml of VSG.
The second clear difference between control and PLC2
trypanosomes is the survival time of the infected mouse,
which was unaffected by passage number and innoculum
size. Although survival time showed a downward trend in
PLC1 infections compared to PLC2 infections, the change
was not statistically significant. It remains to be seen
whether  PLC2 trypanosomes can be modified to express
wild-type levels of GPI-PLC and, if so, whether this would
result in a complete return to wild-type virulence. The sur-
vival time of PLC2 infected mice was apparently longer
than those previously observed for a range of isolates
(Turner et al., 1995), although these values were obtained
in an inbred mouse strain (BALB/c as opposed to CFLP in
this study). The survival time, which can be used as a mea-
sure of virulence, correlates with the initial parasitemia
(Turner et al., 1995), and will be influenced by the geno-
type and epigenetic state of the trypanosome and the host
immune system (Barry and Turner, 1991). Using the data
available, it is not possible to provide a simple explanation
of how the absence of GPI-PLC activity might reduce the
virulence of trypanosomes. However, it is known that T.
brucei causes immunosuppression in the host (Askonas,
1985) and this must be a component of virulence. If GPI-
PLC activity is necessary for the immunosuppression then
it might be expected that PLC2 trypanosomes would be
less virulent than the equivalent wild-type strain.
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